NCT04662151 - A Clinical Safety Study of AT-100 (rhSP-D) in Preterm Neonates at High Risk for Bronchopulmonary Dysplasia (BPD) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

August 14, 2023

Study Completion Date

May 29, 2024

Conditions

Bronchopulmonary Dysplasia

Interventions

BIOLOGICAL

AT-100

reconstituted AT-100 for intratracheal administration

PROCEDURE

Air-sham

room air for intratracheal administration

Trial Locations (19)

11009

Airway Therapeutics Investigational Site, Cadiz

15006

Airway Therapeutics Investigational Site, A Coruña

15706

Airway Therapeutics Investigational Site, Santiago de Compostela

23507

Airway Therapeutics Investigational Site, Norfolk

25198

Airway Therapeutics Investigational Site, Lleida

27705

Airway Therapeutics Investigational Site, Durham

28007

Airway Therapeutics Investigational Site, Madrid

28046

Airway Therapeutics Investigational Site, Madrid

29010

Airway Therapeutics Investigational Site, Málaga

30308

Airway Therapeutics Investigational Site, Atlanta

33143

Airway Therapeutics Investigational Site, Miami

46026

Airway Therapeutics Investigational Site, Valencia

46202

Airway Therapeutics Investigational Site, Indianapolis

72202

Airway Therapeutics Investigational Site, Little Rock

85724

Airway Therapeutics Investigational Site, Tucson

90017

Airway Therapeutics Investigational Site, Los Angeles

02215

Airway Therapeutics Investigational Site, Boston

08041

Airway Therapeutics Investigational Site, Barcelona

03010

Airway Therapeutics Investigational Site, Alicante